EverSource Wealth Advisors’s Anika Therapeutics ANIK Stock Holding History

EverSource Wealth Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.78K	Buy	532 +156	+41%	+$2.31K	﹤0.01%	3056
2026 Q1	$5.45K	Buy	376 +208	+124%	+$2.42K	﹤0.01%	3230
2025 Q4	$1.61K	Buy	168 +120	+250%	+$1.15K	﹤0.01%	3571
2025 Q3	$451	Sell	48 -64	-57%	-$611	﹤0.01%	3974
2025 Q2	$1.19K	Buy	112 +32	+40%	+$404	﹤0.01%	3684
2025 Q1	$1.2K	Sell	80 -39	-33%	-$649	﹤0.01%	3158
2024 Q4	$1.96K	Buy	119 +56	+89%	+$1.1K	﹤0.01%	2716
2024 Q3	$1.56K	Buy	+63	New	+$1.63K	﹤0.01%	2614
2023 Q3	–	Sell	-38	Closed	-$987	–	2500
2023 Q2	$987	Buy	+38	New	+$1.02K	﹤0.01%	2236
2023 Q1	–	Sell	-71	Closed	-$2.1K	–	2383
2022 Q4	$2.1K	Hold	71	–	–	﹤0.01%	1899
2022 Q3	$2K	Buy	71 +9	+15%	+$207	﹤0.01%	1620
2022 Q2	$1K	Hold	62	–	–	﹤0.01%	1617
2022 Q1	$2K	Buy	+62	New	+$1.89K	﹤0.01%	1488

Other funds holding ANIK

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Indivisible Partners Clearwater, Florida $1.77B AUM

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

NCM

Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

EverSource Wealth Advisors's ANIK Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Anika Therapeutics (ANIK) stake by 41% in Q2 2026, buying an estimated $2.31K and bringing the position to 532 shares worth $7.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3056.

EverSource Wealth Advisors first reported a position in ANIK in Q1 2022 and has held it in 13 quarters since. 31 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

EverSource Wealth Advisors held 532 shares of Anika Therapeutics worth $7.78K as of Q2 2026.
EverSource Wealth Advisors bought 156 Anika Therapeutics shares in Q2 2026, an estimated $2.31K.
Anika Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3056 holding.
EverSource Wealth Advisors first reported a position in Anika Therapeutics in Q1 2022 and has held it in 13 quarters since.
31 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.